MAR 31
New Users Please Click to Register
Renew or Upgrade your Existing  Account

Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-2013  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
cme CE free (CME/CE requires payment)
ISHD Hemodialysis University On-Line (2012-2014)











American Society of Hypertension Annual Scientific Meeting (Parts 11-15)   
Flash or IPAD slide/audio
San Francisco, CA; May 2013

Marvin Moser Clinical Hypertension Award Lecture - Treatment of Hypertension: From Drugs to Devices
C. Venkata S. Ram, MD

The Treatment of Hypertension Should be Targeted Towards the Nocturnal Blood Pressure - Antagonist
David A. Calhoun, MD

Home and Ambulatory Blood Pressure Monitoring: Review of the ASH Position Paper
William B. White, MD

Implementing ABPM into Your Practice
Steven A. Yarows, MD

Interpreting the Data in Adult and Pediatric Populations: A Case-Based Approach
Anthony J. Viera, MD

The Asian Hypertensive
Eric T. Mizuno, MD

Adolescents with Hypertension
Joseph T. Flynn, MD

Resistant Hypertension: Incidence, Prevalence, and Pathophysiology
Suzanne Oparil, MD

Patient Case: The Resistant Hypertensive Patient Who Remains Uncontrolled
Jan N. Basile, MD

Symplicity HTN-3 and Resistant Hypertension
George L. Bakris, MD


Hypertension, Cardiovascular
Hyperuricemia review
Lower sodium intake, lower CV risk
Visible ageing signs and CV risk
Methodologic issues in sodium intake studies
MRI to detect CAD
Dabigatran vs. warfarin
Sodium excretion and risk of CAD
Lomitapine and mipomersen lower CHOL big time
Plasma triglycerides, HDL, and risk in type 2 DM
New oral anticoagulants vs. warfarin in a. fib meta
Transcranial magnetic stimulation can cause proteinuria!
Phentermine and topiramate in prediabetes
Immune effects of spironolactone
Vitamin D and resistant hypertension
Spooky sodium balance
Renal denervation SYMPLICITY HTN-3
Evolocumab in hyperlipidemia

CKD, Dialysis
Saturated fatty acids OK
Synopsis of 2013 CHOL guidelines
Warfarin and stroke risk in dialysis patients
Hemodiafiltration does not improve cardiac structure
Ferric citrate hydrate for nondialysis CKD
Warfarin after MI in patients with a. fib.
Age-adjusted D-dimer cutoffs for PE diagnosis
Antioxidant therapy in dialysis patients no good
Accumulation of solutes cleared by tubular secretion
Atenolol better than lisinopril in dialysis patients
Adverse events contributing to death in dialysis patients
ERBP on KDIGO nondialysis CKD BP management
Dietary nitrate lowers metabolic rate
Protein requirements in very old women higher than expected
High BMI and early CKD progression in young adults
Buttonhole no good (randomized trial)
More warfarin vs. dabigatran
Straight PD catheters better than curled (RCT)
Volume estimates in dialysis patients: validation
Health status confounding poor results with venous catheters
Dialysis heparin not needed if taking oral anticoagulants
Spillage of citrate lock from venous catheters
Hemodialysis-associated cardiomyopathy (KEY)

Clinical Nephrology
Hypomagnesemia with PPI in dialysis patients
Kidney stones up CV risk
Levofloxacin no good for BK viremia
Radical prostatectomy better than watchful waiting
Ribavirin for hepatitis E infection in transplant
Diarrhea-positive HUS responds to eculizumab
Ten mistakes in managing lupus nephritis
Tolvaptan pharmacokinetics with reduced GFR
New magnetic resonance imaging methods in nephrology

This update's selected ASN abstracts

HTN Rapid test for salt sensitivity; Renal denervation on ambulatory BP, with multiple arteries; Lipoproteins and progression in CRIC; High total CHOL to HDL good in CKD5D; Cholesterol types and mortality by age and sex.

Recovery of renal function; Anti-HTN meds and outcome; Associates of CP-arrest; Thirst and oral symptoms; Frequent nocturnal HD and QTc interval improvement; Crit-Line good; Bayesian analysis of survival in FHN studies; Cost eval of incenter nocturnal; Mortality in FHN Daily Trial; Mortality in FHN Nocturnal trial; Intensive dialysis and pregnancy outcomes; In-center nocturnal and regression of LV mass; Home dialysis with slow dialysate flow rate; Freq. nocturnal dialysis and cognition. Calcium replacement during CRRT in postfilter replacement fluid; Glutamine and AA removal; Progression: uremic toxins; urine NGAL; serum fetuin; newer biomarkers; renal denervation. Serum selenium and coronary flow reserve; Hypochloremia and mortality risk; FGF23, 25D and 1,25D and infection risk in HEMO; Thiazolidinedione vs. sulfonylurea in dialysis pts.; Elevated non A1c glycemic indices in dialysis pts.; TB test compared. New predictive score for mortality; RAS blocking drugs reduce death risk; Predialysis BP and risk in Japan DOPPS; Sudden death risk in incident HD vs. PD; BP vs. mortality in CONTRAST; Anticoag or antiplatelet drugs and brain events in Japan; Snoring amplifies heart failure risk; NT-proBNP as a marker of risk; FGF and VEGF and CV events; Hypothyroidism in VA patients with CKD.

Clinical Nephrology
Cancer risk in incident dialysis patients.
 (Kidney Week 2013...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: April 16, 2014 (Apr16)
Apr16 Diabetes complication rate in the U.S. shows a sharp decline.
Apr15 NEJM - New drug regimen cures 90% of patients with hepatitis C and cirrhosis.
Apr15 Chromium supplements of no benefit in lowering blood sugar
Mar30 No ischemic EKG changes plus very low cardiac high-sensitivity troponin T levels rule out MI.
Mar30 Symplicity trial discussed by Drs. Gersh and Lerman.
Mar29 Negative SYMPLICITY HTN-3 trial results published in NEJM
Mar29 Evolocumab lowers LDL cholesterol by more than 50% (NEJM)
Mar29 SYMPLICITY HTN - 3: Renal artery denervation fails for resistant hypertension
Mar29 New class of anticholesterol drugs lowers LDL by 50%
Mar17 Large meta-analysis exonerates saturated fat in terms of elevated CV risk.
Mar13 Oxadiazoles make up a new class of antibiotics effective against MRSA.
Mar13 ITPA gene variants markedly affect risk of recurrence of hepatitis C after treatment.
Mar13 Some NSAIDs found to have weak antibacterial activity.
Mar13 Smartphones used to take images of the eye for sharing with health providers.
Mar02 Rare gene deletion that protects the obses against type 2 diabetes identified.
Feb28 Beta-blockade found to benefit ESRD patient survival and CV risk
Feb24 New form of pneumococcal vaccine (Prevnar 13) protects elderly adults.
Feb22 Open Biome (fecal material transplant company) FAQs
Feb22 Fecal transplantation becoming more popular; a company offers collection service.
Feb16 Apple working on heart attack prediction device based on wearable sensor.
General Advances Emphasis
Hemodialysis-associated cardiomyopathy: a newly defined disease entity Drs. McIntyre and Odudu describe their latest results regarding myocardial stunning; in the Mar/Apr issue of Seminars in Dialysis. (more...)

Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants Dr. Clarke and colleagues review why adherence is so important to outcomes, and methods that have been suggested to improve this problem; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Approach to prophylactic measures for central venous catheter- related infections in hemodialysis: A critical review
Dr. Silva and colleagues go over what we know works, and which treatments are still experimental; in the Jan-Feb issue of Hemodial Int (more...)

Infrequent dialysis: a new paradigm for hemodialysis initiation Dr. Rhee and colleagues present a novel idea; starting out with twice-a-week dialysis in incident patients with substantial residual kidney function, and discuss potential benefits vs. risks. in the Nov/Dec issue of Seminars in Dialysis. (more...)

Is it time for "green" dialysis?
Dr. Agar talks about power, water, and waste disposal; in the October issue of Hemodial Int (more...)

Improving outcomes in patients with lupus and end-stage renal disease Inda-Filho and colleagues talk about neglected areas in the management of ESRD patients with lupus nephritis; in the Sep/Oct issue of Seminars in Dialysis. (more...)

Essential components of an infection prevention program for outpatient hemodialysis centers Hess and Bren write about how to set this up, potential pitfalls, and expected benefits; in the July/Aug issue of Seminars in Dialysis. (more...)

Mycophenolate fetal toxicity and risk evaluation and mitigation strategies, including complying with FDA requirements.
Kim, Rostas, and Gabardi discuss the potential problems of using mycophenolate mofetil in pregnancy; in the June issue of Am J Transplantation (more...)

What nephrologists need to know about vascular access cannulation Dinwiddie, Brouwer, and colleagues give valuable tips regarding cannulation of vascular access; in the May/June issue of Seminars in Dialysis. (more...)

Physical examination: How to examine the arm with arteriovenous fistula
Sousa and colleagues review the various methods and pitfalls; in the April issue of Hemodial Int (more...)

Diagnosis and treatment of peripheral arterial disease in CKD patients Yevzlin and Gimelli describe practical algorithms for managing peripheral arterial disease in CKD patients; in the March/April issue of Seminars in Dialysis. (more...)

When should a patient receive an arteriovenous graft rather than a fistula? Lee and Allon discuss those instances where it may be advantageous to consider AV graft first; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Debate: Peritoneal dialysis should be the first choice for renal replacement therapy in the elderly Bargman vs. Mallappallil and colleagues argue about the benefits of a PD first strategy in this age group; in the Nov/Dec issue of Seminars in Dialysis. (more...)

New insights on molecular mechanisms of renal aging
Schmitt and Melk discuss new knowledge about pathologic vs. physiologic aging in the kidneys; in the November issue of Am J Transplantation (more...)

  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

  Advances in CKD (Renal Research Institute) (2013) (2012) (2011) (2010) (2009)
  Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
  The Brigham Renal Board Review Course: Selected Lectures (2012) (2011)
  American Society of Hypertension (2013)   (2012)   (2011)
  Renal Physicians Association (2012) (2011) (2010) (2009)
  American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
  Fistula First (2010)
  Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
  National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
  American Society for Nephrology Renal Week (2009) (2008) (2007)
  American Society for Nephrology Board Review Course (2008) (2007)
  American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99